Moderna

When Moderna was founded, it was a research-stage biotech with an unconventional scientific thesis and no commercial products. What it did have, from early on, was a conviction that digital infrastructure was not optional. It was foundational. In 2016, the company partnered with Answerthink^® to build an integrated finance and supply chain platform on SAP S/4HANA Cloud Private Edition, establishing a digital core that would prove critical in ways no one could have anticipated.

When COVID-19 emerged and Moderna’s mRNA vaccine became one of the world’s most urgent priorities, that foundation didn’t just hold – it scaled. The company went from pre-commercial biotech to over $28 billion in annual revenue in a single year, mobilizing global supply chains, meeting international serialization and regulatory requirements, and distributing millions of doses worldwide. The SAP platform Answerthink^® helped build was the infrastructure that made it possible.

Challenges

As Moderna transitioned from a research-focused organization to a global commercial manufacturer, it faced operational demands that would have overwhelmed systems built for a smaller scale:

• Rapid mobilization of global supply chains to support vaccine manufacturing and distribution at unprecedented volume
• International serialization and traceability requirements to prevent counterfeit medicines and meet country-specific regulatory mandates
• Seamless integration across finance, procurement, manufacturing and supply chain in a single, unified platform
• Secure data exchange with global supply chain partners across multiple markets and regulatory environments
• The need to scale digital infrastructure at the same pace as the business without disruption to operations

Why SAP and Answerthink^®

Moderna’s founding leadership made an early and deliberate choice: digitalization from the ground up was not just an opportunity but a requirement. As Stéphane Bancel, Moderna’s founding CEO, put it: “It was very clear to me from day one that infusing digitalization from the ground up was not only an opportunity but a requirement for our company to succeed.”

Rather than deploy point solutions, the company sought a long-term strategic platform that could grow with the business. Answerthink^® was selected for its deep life sciences expertise and its ability to position SAP not as a software implementation but as a strategic digital core – one that could support compliance, traceability and global operations at scale. Tom Reul, senior account executive at Answerthink^®, noted in coverage of the engagement, “Without knowledge of COVID-19 even coming down the line, Moderna was able to support the transition from a startup to a leader in the vaccine market.”

The United VARS alliance extended that capability across international markets, ensuring country-specific requirements were met as Moderna’s global footprint expanded.

Together, SAP and Answerthink^® delivered:

• SAP S/4HANA as the integrated digital core across finance, procurement and supply chain
• A single source of truth for financial and operational data across global markets
• Built-in compliance and traceability capabilities aligned to international pharmaceutical regulations
• A scalable architecture capable of supporting growth from startup to global commercial leader
• Global implementation support through the United VARS alliance

Implementation highlights

Answerthink^® delivered a phased SAP implementation designed to scale alongside Moderna’s rapid growth while maintaining stability across a complex and evolving information technology (IT) landscape:

• SAP S/4HANA deployed as the digital core for finance, supply chain and procurement
• SAP Ariba, Concur, Fieldglass and SuccessFactors Learning integrated into the platform
• SAP Advanced Track and Trace for Pharmaceuticals implemented for serialization and global compliance
• Third-party integrations, including MES, LIMS, and Workday, established within a unified data environment
• Phased rollout strategy enabling continuous capability expansion without disrupting operations

Outcome

The SAP platform Answerthink^® built for Moderna proved its value not just at launch, but at a scale no one had planned for. When global demand for Moderna’s COVID-19 vaccine emerged, the company’s digital infrastructure was ready.

• Scaled from pre-commercial biotech to over $28 billion in annual revenue in a single year – supported by an integrated SAP platform
• Mobilized global supply chains rapidly to manufacture and distribute COVID-19 vaccines across international markets
• Met complex serialization and traceability requirements across multiple countries and regulatory regimes
• Maintained operational control and financial visibility through a period of unprecedented growth
• Established a resilient digital backbone that continues to support Moderna’s mRNA innovation pipeline

“SAP and Answerthink^® were able to combine our expertise in life science to help Moderna build their S/4HANA-centric intelligent enterprise while supporting their rapid global expansion and meeting all the regulatory compliance requirements.”

— John McGrath, Principal and Managing Director, Answerthink^®

Moderna is now recognized as a leading digital biotech – one whose ability to move from laboratory to global scale was built, in part, on the foundation Answerthink^® helped establish.